Brian DeBosch's study highlights the connection between urea cycle defects and fatty liver disease development. Urea cycle issues lead to TCA cycle impairment, causing inefficient calorie utilization and fat accumulation.
There are no approved treatments for pediatric fatty liver diseases like MASLD and MASH. DeBosch's research aims to address the urgent need for interventions in these rapidly increasing conditions.
Collection
[
|
...
]